SNAP heads into the post-earnings period in a notably different shape than it entered it — short sellers are covering, the stock has rebounded 32% in a month, and yet options traders just raised their most defensive reading in weeks.
The most striking move is in how aggressively shorts have unwound since late April. Short interest peaked at nearly 11.8% of the free float on April 20, immediately after SNAP reported Q1 results. From there, bears retreated fast: SI % FF has fallen to 9.6%, shedding more than two percentage points in under three weeks. That covers roughly 24 million shares returning to the lending pool — a significant exit for a stock at $6.11. Cost to borrow confirms the loosening. It has dropped 29% over the past month to just 0.36% annually, about as cheap as it gets for a name that still carries $10B in enterprise value. Borrow availability remains ample; there is no squeeze dynamic in play.
Options, however, are telling a contrasting story. Put/call ratio jumped to 0.32 on May 5 — more than three standard deviations above its 20-day average of 0.24. That is the most defensive options positioning SNAP has seen since the PCR briefly touched 0.57 in mid-2025. The re-rating happened in a single session. On May 4 the PCR was a routine 0.25; one day later it nearly doubled. Something — macro jitters, a position hedge, or a tactical put buyer after the 32% run — drove a sharp spike in downside protection demand. Short covering says the durable bears have faded; options buyers say near-term nervousness is high. That divergence defines the current positioning setup.
The Street's reaction to earnings was mixed-but-tilted-cautious. Most analysts maintained their ratings after the Q1 print, with the majority clustered on Hold or Neutral. BMO Capital stands out as the clear bull, carrying an Outperform with a $15 target — sharply above the Street mean of $7.90. The consensus of 8 Buys against 29 Holds reflects a market that sees limited near-term upside rather than a recovery story. The EV/EBITDA multiple has compressed by 1.3 turns over the past month to 9.4x, a modest re-rating lower even as the share price rallied — a sign the Street is upgrading earnings expectations faster than it is re-rating the stock. EPS momentum scores rank in the 93rd percentile on a 30-day basis and 86th on a 90-day view, suggesting forward estimates are moving up briskly. The analyst recommendation divergence rank (95th percentile) flags that the bull-bear split among analysts is unusually wide right now — BMO's $15 sits almost 90% above where Canaccord and Wells Fargo anchor their targets near $6.
On the ownership side, the co-founder and CEO Evan Spiegel sold 1 million shares on April 8 for roughly $5 million. The CFO and another C-suite officer also made smaller sales in March and April. Net insider activity over 90 days is a modest positive ($18.5M net on a share-count basis) but driven by stock awards rather than open-market purchases — the outright selling by the founder after a difficult few months is worth noting. Tencent remains the single largest holder at 14.4%, unchanged in the most recent filing period.
The last earnings print, reported February 4, sent the stock down 16% the next day and 18% over the following five trading sessions — a sharp negative reaction that likely drove the April short-interest build. The subsequent squeeze off the mid-April lows as Q1 results came in better-than-feared explains much of the current short covering. What to watch next: whether the PCR spike on May 5 marks the start of sustained defensive positioning as the stock tests resistance near $6.30, or whether it fades as quickly as it appeared once the macro noise clears.
See the live data behind this article on ORTEX.
Open SNAP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
